Esophageal Stents Market Size, Share, Industry Trends and Forecast to 2030

Esophageal Stents Market Size & CAGR in 2021

The global esophageal stents market is projected to have a growth rate of 4.2% CAGR from 2021 to 2026. As a result, the market is expected to reach a value of USD 318.4 million by 2026.

COVID-19 Impact on the Esophageal Stents Market

The COVID-19 pandemic has had a significant impact on the esophageal stents market. The restrictions imposed due to the pandemic led to delayed procedures and surgeries, affecting the demand for esophageal stents. However, with the gradual reopening of healthcare facilities and the resumption of elective procedures, the market is expected to recover in the coming years.

Esophageal Stents Dynamics

The esophageal stents market is driven by the increasing incidence of esophageal cancer and other esophageal disorders. The rising aging population, changing lifestyle patterns, and advancements in stent technology are also contributing to market growth. However, the market faces challenges such as complications associated with stent placement and limited awareness about esophageal stents in some regions.

Segments and Related Analysis

By Type:

- Self-Expandable Metal Stents (SEMS)

- Plastic Stents

By Application:

- Malignant Dysphagia

- Benign Esophageal Strictures

By End-User:

- Hospitals

- Ambulatory Surgical Centers

By Region Analysis

- North America: The North American esophageal stents market is expected to dominate the global market due to the high prevalence of esophageal cancer and well-established healthcare infrastructure.

- Europe: The European market is anticipated to witness significant growth, driven by increasing research and development activities and rising adoption of advanced stent technologies.

- Asia Pacific: The Asia Pacific market is projected to grow rapidly, attributed to the increasing healthcare expenditure, rising awareness about esophageal disorders, and growing geriatric population.

- Latin America: The Latin American market is likely to show steady growth, supported by improving healthcare facilities and increasing collaborations between manufacturers and healthcare providers.

- Middle East and Africa: The MEA market is expected to experience moderate growth due to the expanding healthcare infrastructure and initiatives to enhance patient care.

Key Market Players and Competitive Landscape

Key players in the esophageal stents market include Boston Scientific Corporation, Cook Medical, Merit Medical Systems, ELLA-CS, and Olympus Corporation. These companies are focusing on product innovation, strategic partnerships, and acquisitions to strengthen their market presence.

Recent Happenings in the Esophageal Stents Market

- In March 2021, Boston Scientific Corporation announced the launch of its Axios™ stent and electrocautery-enhanced delivery system for endoscopic ultrasound-guided gastroenterology procedures.

- In June 2021, Cook Medical introduced its Evolution® Esophageal Controlled-Release Stent to provide palliative treatment for esophageal strictures and fistulas.

- In September 2021, Merit Medical Systems acquired Brightwater Medical to enhance its portfolio of stents and related products for gastrointestinal applications.

- In November 2021, ELLA-CS received FDA clearance for its Bioactive Esophageal Stent, designed to improve patient outcomes in the treatment of esophageal malignancies.

- In January 2022, Olympus Corporation launched its SX-Alpha Esophageal Stent System with a novel delivery system for precision placement and improved patient comfort.